Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
14.10
+0.32 (2.32%)
At close: Oct 8, 2025, 4:00 PM EDT
14.10
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:04 PM EDT

Benitec Biopharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
Operating Revenue
--0.080.070.06
Upgrade
--0.080.070.06
Upgrade
Revenue Growth (YoY)
--2.74%23.73%-42.16%
Upgrade
Cost of Revenue
--0.11-0.010.12
Upgrade
Gross Profit
-0.110.080.06-0.06
Upgrade
Selling, General & Admin
23.436.996.386.656.51
Upgrade
Research & Development
18.3315.6112.7711.277.02
Upgrade
Operating Expenses
41.7722.619.1617.9213.53
Upgrade
Operating Income
-41.77-22.49-19.08-17.85-13.6
Upgrade
Interest Expense
---0.03-0.03-0.01
Upgrade
Interest & Investment Income
3.290.9---
Upgrade
Currency Exchange Gain (Loss)
-0.070.04-0.42-0.23-0.33
Upgrade
Other Non Operating Income (Expenses)
-0.13-0.2-0.03-0.08-
Upgrade
EBT Excluding Unusual Items
-38.68-21.75-19.56-18.2-13.94
Upgrade
Gain (Loss) on Sale of Investments
--0-0-0.010.02
Upgrade
Other Unusual Items
0.76---0.04
Upgrade
Pretax Income
-37.92-21.75-19.56-18.21-13.88
Upgrade
Net Income
-37.92-21.75-19.56-18.21-13.88
Upgrade
Preferred Dividends & Other Adjustments
-0.62---
Upgrade
Net Income to Common
-37.92-22.37-19.56-18.21-13.88
Upgrade
Shares Outstanding (Basic)
3618100
Upgrade
Shares Outstanding (Diluted)
3618100
Upgrade
Shares Change (YoY)
97.17%1225.17%188.30%90.24%320.63%
Upgrade
EPS (Basic)
-1.05-1.22-14.12-37.88-54.94
Upgrade
EPS (Diluted)
-1.05-1.22-14.12-37.88-54.94
Upgrade
Free Cash Flow
-23.61-19.58-18.01-15.91-13.05
Upgrade
Free Cash Flow Per Share
-0.65-1.07-13.00-33.10-51.66
Upgrade
Gross Margin
--100.00%87.67%-108.47%
Upgrade
Operating Margin
---25441.33%-24457.53%-23044.07%
Upgrade
Profit Margin
---26082.67%-24942.47%-23528.81%
Upgrade
Free Cash Flow Margin
---24017.33%-21797.26%-22123.73%
Upgrade
EBITDA
-41.7-22.4-18.95-17.69-13.37
Upgrade
D&A For EBITDA
0.070.090.140.170.23
Upgrade
EBIT
-41.77-22.49-19.08-17.85-13.6
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q